Update on the use of pramipexole in the treatment of Parkinson’s disease

  title={Update on the use of pramipexole in the treatment of Parkinson’s disease},
  author={Radu Constantinescu},
  journal={Neuropsychiatric Disease and Treatment},
  pages={337 - 352}
Pramipexole is a non-ergot dopamine agonist shown to be efficacious in the treatment of Parkinson's disease (PD). This review addresses the literature concerning pramipexole's efficacy in treating motor and non-motor symptoms in PD, its impact on the development of dyskinesias and response fluctuations, the issue of neuroprotection, and the risk for developing adverse events such as increased somnolence, attacks of sudden onset of sleep, cardiac valvulopathy and impulse control disturbances. 


Publications citing this paper.
Showing 1-10 of 13 extracted citations


Publications referenced by this paper.
Showing 1-10 of 143 references

Risk factors for somnolence, edema, and hallucinations in early Parkinson disease

  • KM Biglan, RG JrHolloway, MP McDermott
  • Neurology
  • 2007
Highly Influential
4 Excerpts

Long - term effi cacy and safety of pramipexole in advanced Parkinson ’ s disease : results from a European multicenter trial

  • JC Moller, WH Oertel, J Koster
  • Mov Disord
  • 2005
Highly Influential
3 Excerpts

Similar Papers

Loading similar papers…